{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:55:21Z","timestamp":1789703721540,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["281035"],"award-info":[{"award-number":["281035"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jconrel.2017.02.024","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T01:31:05Z","timestamp":1487727065000},"page":"4-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers"],"prefix":"10.1016","volume":"263","author":[{"given":"Zhigao","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alo\u00efse","family":"Mabondzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Monia","family":"Montagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Marigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez-Touceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulay","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Santander-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.02.024_bb0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jconrel.2012.03.017","article-title":"Chitosan-based drug nanocarriers: where do we stand?","volume":"161","author":"Garcia-Fuentes","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0020","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","article-title":"Oral delivery of therapeutic protein\/peptide for diabetes\u2014future perspectives","volume":"440","author":"Rekha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0030","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4155\/tde.11.128","article-title":"Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies","volume":"2","author":"Griffin","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2016.04.014","article-title":"Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier","author":"Beloqui","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0045","series-title":"A Two-week Randomized Active Comparator Study of Two HDV-insulin Routes (SC and Oral) and SC Human Insulin in Patients With Type 1 Diabetes Mellitus","author":"Sherwyn","year":"2015"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0050","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.clinthera.2012.11.004","article-title":"Time\u2013action profile of an oral enteric insulin formulation in healthy Chinese volunteers","volume":"34","author":"Li","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0055","unstructured":"A. Vol, O. Gribova, Methods and compositions for oral administration of protein and peptide therapeutic agents, in, Google Patents, 2010."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11095-006-9570-8","article-title":"Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery","volume":"23","author":"Prego","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0070","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1166\/jnn.2006.429","article-title":"Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness","volume":"6","author":"Prego","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","article-title":"Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree","volume":"111","author":"Prego","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-013-1515-7","article-title":"Polyarginine nanocapsules: a new platform for intracellular drug delivery","volume":"15","author":"Lozano","year":"2013","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2016.09.029","article-title":"Polyarginine nanocapsules as a potential oral peptide delivery carrier","author":"Lollo","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0090","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/js980125q","article-title":"Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid","volume":"87","author":"Suzuki","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0006-2952(99)00377-9","article-title":"effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats","volume":"59","author":"Lo","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2004.03.010","article-title":"Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery","volume":"97","author":"Onuki","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0105","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.bbamem.2011.08.012","article-title":"Lipophilic penetration enhancers and their impact to the bilayer structure of stratum corneum lipid model membranes: neutron diffraction studies based on the example oleic acid","volume":"1808","author":"Engelbrecht","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.addr.2012.07.012","article-title":"Fatty acids as therapeutic auxiliaries for oral and parenteral formulations","volume":"65","author":"Hackett","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.01.022","article-title":"Evaluation of pharmacological efficacy of 'insulin-surfoplex' encapsulated polymer vesicles","volume":"373","author":"Rastogi","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0120","first-page":"3049","article-title":"Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin","volume":"6","author":"Sun","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jcis.2006.07.031","article-title":"Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms","volume":"302","author":"Santander-Ortega","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s003960050050","article-title":"Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsions","volume":"275","author":"Calvo","year":"1997","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2014.02.004","article-title":"Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel","volume":"87","author":"Lollo","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0140","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2009.05.069","article-title":"The gastrointestinal stability of lipid nanocapsules","volume":"379","author":"Roger","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diab.37.2.246","article-title":"New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier","volume":"37","author":"Damg\u00e9","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-3659(90)90013-J","article-title":"Nanocapsules as carriers for oral peptide delivery","volume":"13","author":"Damg\u00e9","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0160","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1023\/A:1007574030674","article-title":"Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions","volume":"17","author":"Watnasirichaikul","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-5173(02)00002-9","article-title":"Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w\/o microemulsions","volume":"235","author":"Watnasirichaikul","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2015.05.031","article-title":"Design of the interface of edible nanoemulsions to modulate the bioaccessibility of neuroprotective antioxidants","volume":"490","author":"Plaza-Oliver","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0175","series-title":"Viscosity of LiquidsTheory, Estimation, Experiment, and Data","author":"Viswanath","year":"2007"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0180","year":"2008","journal-title":"Prog. Colloid Polym. Sci."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(98)00210-5","article-title":"Improving insulin enteral absorption using water-in-oil-in-water emulsion","volume":"172","author":"Morishita","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0190","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1018906330308","article-title":"Alveolar permeability enhancement by oleic acid and related fatty acids: evidence for a calcium-dependent mechanism","volume":"11","author":"Wang","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0195","series-title":"Intermolecular and Surface Forces","author":"Israelachvili","year":"2011"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2013.06.014","article-title":"A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging","volume":"170","author":"Bastiat","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2007.03.009","article-title":"Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization","volume":"340","author":"Liu","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpb.2013.07.017","article-title":"Solid lipid particles for oral delivery of peptide and protein drugs I\u2014elucidating the release mechanism of lysozyme during lipolysis","volume":"85","author":"Christophersen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2004.12.030","article-title":"New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin","volume":"296","author":"Garcia-Fuentes","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0230","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s11095-014-1324-4","article-title":"A mechanism enhancing macromolecule transport through paracellular spaces induced by poly-l-arginine: poly-l-arginine induces the internalization of tight junction proteins via clathrin-mediated endocytosis","volume":"31","author":"Yamaki","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/17425247.2.5.843","article-title":"The potential of chitosan for the oral administration of peptides","volume":"2","author":"Prego","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0240","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejpb.2008.03.004","article-title":"Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells","volume":"70","author":"Sadeghi","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2017.02.024_bb0250","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.jconrel.2011.08.078","article-title":"An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid","volume":"152","author":"Zhao","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/00365529409090437","article-title":"Alteration of colonic absorption by long-chain unsaturated fatty acids. Influence of hydroxylation and degree of unsaturation","volume":"29","author":"Ramakrishna","year":"1994","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0260","series-title":"Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals","first-page":"605","article-title":"Protein stability during bioprocessing","author":"Manning","year":"2010"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2005.10.029","article-title":"Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats","volume":"110","author":"Morishita","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.024_bb0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.024_bb0275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:21:08Z","timestamp":1589718068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":54,"alternative-id":["S0168365917300858"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}